Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-04-30, Stock:JNJ, The news for the past five days is as follows:
2018-04-23: NEWS1: Johnson & Johnson’s Revenues Continued to Rise in 1Q18.NEWS2: Drug/Biotech Stock Q1 Earnings Due on Apr 24: LLY, BIIB, AMGN.NEWS3: Drug/Biotech Stock Q1 Earnings Due on Apr 24: LLY, BIIB, AMGN.NEWS4: Johnson & Johnson's Top-Line Growth Isn't What It Seems.NEWS5: Johnson & Johnson's Top-Line Growth Isn't What It Seems.NEWS6: Analysts’ Estimates for Eli Lilly & Co.’s 1Q18 Earnings.NEWS7: Johnson & Johnson&apos;s Top-Line Growth Isn&apos;t What It Seems.NEWS8: Geron Corporation: The Clock Is Ticking.NEWS9: Geron Corporation: The Clock Is Ticking.NEWS10: Geron Corporation: The Clock Is Ticking.NEWS11: Why GlaxoSmithKline’s 1Q18 Revenues Are Expected to Fall.NEWS12: Merck’s Relebactam Met Primary Endpoints in Phase 3 Study.NEWS13: British businesses embrace profits with a purpose.
2018-04-24: NEWS1: Top Research Reports for Johnson & Johnson, Honeywell & Morgan Stanley.NEWS2: Top Research Reports for Johnson & Johnson, Honeywell & Morgan Stanley.NEWS3: Top Research Reports for Johnson & Johnson, Honeywell & Morgan Stanley.NEWS4: Johnson & Johnson to Participate in the 2018 Deutsche Bank 43rd Annual Health Care Conference.NEWS5: Biktarvy Could Be a Major Driver for Gilead Sciences in 2018.NEWS6: NEWS BITES: Police look for motive in deadly Toronto van attack, President George H.W. Bush hospitalized, Prince's family suing hospital that treated him.NEWS7: How Johnson & Johnson’s Pharmaceutical Segment Performed in 1Q18.NEWS8: Analyzing Johnson & Johnson’s Segment-Wise Performance in 1Q18.
2018-04-25: NEWS1: J&J Gets Court to Throw Out $151 Million Artificial Hip Verdict.NEWS2: Buy the Post-Earnings Lull from Johnson & Johnson.NEWS3: Buy the Post-Earnings Lull from Johnson & Johnson.NEWS4: Johnson & Johnson’s Revenue at $20 Billion in 1Q18.NEWS5: Drug Stock Q1 Earnings Due on Apr 26: ABBV, ALXN, BMY & VRTX.NEWS6: Drug Stock Q1 Earnings Due on Apr 26: ABBV, ALXN, BMY & VRTX.NEWS7: Buy the Post-Earnings Lull from Johnson & Johnson.NEWS8: Novartis Launches FocalView to Modernize Clinical Trials.NEWS9: Amgen’s Earnings Grow 12% Year-Over-Year in 1Q18.NEWS10: How Analysts Rate Bristol-Myers Squibb in 1Q18.NEWS11: The Zacks Analyst Blog Highlights: Johnson & Johnson, Honeywell, Morgan Stanley, Novartis and eBay.NEWS12: The Zacks Analyst Blog Highlights: Johnson & Johnson, Honeywell, Morgan Stanley, Novartis and eBay.NEWS13: Should OShares FTSE U.S. Quality Dividend ETF (OUSA) Be on Your Investing Radar?.NEWS14: Should OShares FTSE U.S. Quality Dividend ETF (OUSA) Be on Your Investing Radar?.NEWS15: How Did Johnson & Johnson’s Consumer Segment Perform in 1Q18?.NEWS16: The Zacks Analyst Blog Highlights: Johnson & Johnson, Honeywell, Morgan Stanley, Novartis and eBay.NEWS17: What Do Analysts Predict for Bristol-Myers Squibb in 1Q18?.NEWS18: How Johnson & Johnson’s Medical Devices Segment Performed in 1Q18.
2018-04-26: NEWS1: Abbvie Up over 6% on 1Q18 Earnings Beat, Raised Earnings Forecast.NEWS2: AbbVie (ABBV) Q1 Earnings Beat, 2018 View Up, Stock Gains.NEWS3: AbbVie (ABBV) Q1 Earnings Beat, 2018 View Up, Stock Gains.NEWS4: Daily Dividend Report: JNJ, XOM, POR, CVX, LMT.NEWS5: Daily Dividend Report: JNJ, XOM, POR, CVX, LMT.NEWS6: Bristol-Myers (BMY) Beats on Q1 Earnings, Opdivo Impresses.NEWS7: Bristol-Myers (BMY) Beats on Q1 Earnings, Opdivo Impresses.NEWS8: Notable ETF Outflow Detected - IWB, JPM, JNJ, UNH.NEWS9: Notable ETF Outflow Detected - IWB, JPM, JNJ, UNH.NEWS10: How Analysts Rate JNJ after 1Q18 Earnings.NEWS11: Johnson & Johnson Announces Dividend Increase of 7.1%.NEWS12: Bristol-Myers (BMY) Beats on Q1 Earnings, Opdivo Impresses.NEWS13: Bristol-Myers Squibb’s 1Q18 Earnings Beat Wall Street Estimates.NEWS14: Should PowerShares Dividend Achievers Portfolio (PFM) Be on Your Investing Radar?.NEWS15: Should PowerShares Dividend Achievers Portfolio (PFM) Be on Your Investing Radar?.NEWS16: What’s Johnson & Johnson’s Valuation after 1Q18 Earnings?.NEWS17: What Wall Street Analysts Estimate for Johnson & Johnson.NEWS18: Johnson & Johnson wins appeal to overturn $151 million hip implant verdict.NEWS19: J&J wins appeal to overturn $151 million hip implant verdict.
2018-04-27: NEWS1: Biotech Stocks Facing FDA Decision In May.NEWS2: Biotech Stocks Facing FDA Decision In May.NEWS3: GlaxoSmithKline’s 1Q18 Earnings: Performance by Segment.NEWS4: Vertex (VRTX) Q1 Earnings Beat on Strong CF Products Sales.NEWS5: Vertex (VRTX) Q1 Earnings Beat on Strong CF Products Sales.NEWS6: Allergan’s 1Q18 Estimates: Expect Growth in Revenues.NEWS7: Daily Chatter: Trillion Dollar Babies.

Answer: Decrease